glp 1 agonist and dementia Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease Parkinson's disease | Journal of Biomedical Science Mapping the effectiveness and risks

Nutrition and food literacy: framing the challenges to health communication

Various studies have shown that GLP-1RAs have a kidney protective effect in patients with T2D, when considering the safety and effectiveness of GLP-1RAs in comparison to other anti-diabetic medications [100], [101], [102], [103], [104], [105]

Sleep apnea occurs when a person's upper airway becomes blocked while they snooze, causing pauses in their breathing that awaken them

Unfortunately, no data on bone metabolism were available [21]

25 Although data from clinical studies on liraglutide revealed a 7% increase in serum amylase and a 31% increase in serum lipase in patients after four weeks of GLP-1 receptor agonist treatment compared with placebo, the increased levels reverted to normal once therapy was discontinued and did not predict acute pancreatitis onset